« Previous
Next »
Placenta
Volume 31, Issue 3
, Pages 222-229
, March 2010
Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: Gestational diabetes mellitus, intrauterine growth restriction and preeclampsia
References
- Effect of peroxisome proliferator-activated receptor d on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A. 2002;99:303–308
- PPARγ is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4:585–595
- . Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(Suppl. 2):S112–S119
- . p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha – a potential role in the cardiac metabolic stress response. J Biol Chem. 2001;276:44495–44501
- . Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28:67–80
- . Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol. 1996;36:239–247
- . Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454:470–477
- . Actin up in the nucleus. Nat Rev Mol Cell Biol. 2004;5:410–415
- . Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol. 2007;197(516):e1–e6
- The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol. 2000;40:133–138
- . What is gestational diabetes?. Diabetes Care. 2007;30:S105–S111
- . Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem. 1997;272:10811–10816
- . Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab. 2002;282:E522–E533
- . Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol. 2000;183:853–858
- . Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes. J Clin Endocrinol Metab. 2004;89:3585–3594
- . DNA binding-independent induction of IκBa gene transcription by PPARα. Mol Endocrinol. 2002;16:1029–1039
- Peroxisome proliferator-activated receptor-a activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci. 2003;23:6264–6271
- . Programmed upregulation of adipogenic transcription factors in intrauterine growth-restricted offspring. Reprod Sci. 2008;15:785–796
- . The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30(Suppl. 2):S120–S126
- . The PPARa-leukotriene B4 pathway to inflammation control. Nature. 1996;384:39–43
- Peroxisome proliferator-activated receptor delta expression and regulation in mouse uterus during embryo implantation and decidualization. Mol Reprod Dev. 2003;66:218–224
- . Placental 11ß-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta. 2008;29:193–200
- . Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541–H550
- . Update of growth percentiles for infants born in an Australian population. Aust N Z J Obstet Gynaecol. 1994;34:39–50
- . Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis. 2009;3:65–73
- . Gestational diabetes mellitus–management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust. 1998;169:93–97
- . Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor. Reproduction. 2009;137:1007–1015
- . Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes. Placenta. 2009;30:176–186
- . Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970–975
- The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells. Proc Natl Acad Sci U S A. 2005;102:1460–1465
- Influence of peroxisome proliferator-activated receptorγ activation by its endogenous ligand 15-deoxy Δ12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod. 2004;10:671–676
- . Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem. 2006;13:2127–2138
- . Maternal pathophysiology in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 1999;13:59–75
- . Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res. 2001;56:239–265
- . Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod. 2002;67:668–673
- . Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89:5627–5633
- . Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kB and IkB kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology. 2005;146:1491–1497
- Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 1999;13:1561–1574
- . Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402–408
- . Peroxisome proliferator-activated receptor a activation regulates lipid metabolism in the feto-placental unit from diabetic rats. Reproduction. 2008;136:95–103
- . Intrauterine growth restriction–genetic causes and consequences. Semin Fetal Neonatal Med. 2004;9:371–378
- . Revision of guidelines for the management of gestational diabetes mellitus. Med J Aust. 2004;181:342
- . Reduction of the human placental vascular relaxation to progesterone by gestational diabetes. J Matern Fetal Investig. 1998;8:27–30
- . Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499–506
- . Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41:437–445
- . Human placental peroxisome proliferator-activated receptor δ and γ expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig. 2005;12:320–329
- . Peroxisome proliferator-activated receptor-γ and retinoid x receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab. 2005;90:4267–4275
- Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18:1692–1700
- The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003;100:9968–9973
- . PPAR agonists and the metabolic syndrome. Therapie. 2007;62:319–326
- Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol. 2006;155:567–574
- PPARγ/RXRα heterodimers control human trophoblast invasion. J Clin Endocrinol Metab. 2001;86:5017–5024
- The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta. Eur J Pharmacol. 2006;549:124–132
- Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes. Mol Cell Endocrinol. 1999;154:101–109
- . Preeclampsia, an implantation disorder. Rev Endocr Metab Disord. 2002;3:151–158
- . Circulating activators of peroxisome proliferator-activated recpetors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab. 2005;90:620–626
- . Pre-eclampsia. Lancet. 2000;356:1260–1265
- . Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem. 2001;70:341–367
- . PPARα deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes melitus: modultion of T cell differentiation. Endocrinology. 2006;147:4410–4418
- The differential effects of the timing of maternal nutrient restriction in the ovine placenta on glucocorticoid sensitivity, uncoupling protein 2, PPAR-gamma and cell proliferation. Reproduction. 2009;138(3):601–608
PII: S0143-4004(09)00399-3
doi: 10.1016/j.placenta.2009.12.009
« Previous
Next »
Placenta
Volume 31, Issue 3
, Pages 222-229
, March 2010
